Pyoderma Gangrenosum: An Update - 15/08/11
, J. Mark Jackson, MDAbstract |
Pyoderma gangrenosum (PG) can be differentiated into classic and atypical forms. The classic form is characterized by ulcers and the atypical form by deep erosions with bullous blue-gray margins. Pathergy, the development of cutaneous lesions at sites of trauma, is a common feature of both forms of PG. Approximately 50% of patients who have PG have underlying systemic diseases, most commonly inflammatory bowel disease, myeloproliferative disorders, and various forms of inflammatory arthritis. The diagnosis of PG is one of exclusion. The management of this disorder begins with treatment of any underlying disease and local or systemic glucocorticoids or immunomodulating therapies.
Il testo completo di questo articolo è disponibile in PDF.Mappa
| Dr. Jackson has received funding for research, honoraria, consulting, and/or other support from the following companies: 3M, Abbott, Amgen, Biogen, Centocor, CollaGenex, Connetics, Ferndale, Galderma, Genentech, Novartis, and Roche. Dr. Callen has received honoraria, consulted for, or served as a safety monitor for Amgen, Abbott, Centocor, Genmab, Electrical Optical Sciences, and Stiefel. |
Vol 33 - N° 4
P. 787-802 - novembre 2007 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
